Dietlind Zohlnhöfer

Author

Dietlind Zohlnhöfer

Also Known As

D. Zohlnhofer, D. Zohlnhöfer, Dietlind Zohlnhofer, Dietlind Zohlnhöfer, Dietlind Zohlnhöfer, Dietlind Zohlnhöfer (615758), Jasper von Wedel, Zohlnhöfer, D.

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Deutsches Herzzentrum der Charité Technical University of Munich Berlin-Brandenburger Centrum für Regenerative Therapien Klinikum rechts der Isar Charité - Universitätsmedizin Berlin

About

Dietlind Zohlnhöfer is an author at Deutsches Herzzentrum der Charité specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.2K
2	Cell Biology	9	9	1.2K
3	Health Sciences	2	2	536
4	Natural Sciences	1	1	56
5	Biomedical Engineering	1	1	504

Dietlind Zohlnhöfer

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
A Crucial Role of Glycoprotein VI for Platelet Recruitment to the Injured Arterial Wall In Vivo Meinrad Gawaz, Sabine Grüner, Valerie Schulte, The Journal of Experimental Medicine Vascular DiseaseImmunologyGlycoprotein ViBiomedical EngineeringInflammation	2002	504
Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients With Acute Myocardial Infarction<SUBTITLE>A Randomized Controlled Trial</SUBTITLE> Dietlind Zohlnhöfer JAMA	2006	429
Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction F. Neumann, Dietlind Zohlnhöfer, Leila Fakhoury, Journal of the American College of Cardiology InflammationThrombosisThrombopoiesisCardiovascular DiseaseBlood Platelet	1999	240
Randomized Evaluation of the Effects of Filter-Based Distal Protection on Myocardial Perfusion and Infarct Size After Primary Percutaneous Catheter Intervention in Myocardial Infarction With and Without ST-Segment Elevation Michael Gick, Nikolaus Jander, Hans-Peter Bestehorn, Circulation	2005	228
Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis Jörg Hausleiter, Adnan Kastrati, Julinda Mehilli, Circulation	2004	166
The hepatic interleukin‐6 receptor Down‐regulation of the interleukin‐6 binding subunit (gp80) by its ligand Dietlind Zohlnhöfer, Lutz Graeve, Stefan Rose‐John, FEBS Letters Immune RegulationImmunologyImmunologic MechanismInnate ImmunityImmune System	1992	140
Gene Expression Profiling of Human Stent-Induced Neointima by cDNA Array Analysis of Microscopic Specimens Retrieved by Helix Cutter Atherectomy Dietlind Zohlnhöfer, Christoph A. Klein, Thomas Richter, Circulation	2001	124
Transcriptome Analysis Reveals a Role of Interferon-γ in Human Neointima Formation Dietlind Zohlnhöfer, Thomas Richter, Franz–Josef Neumann, Molecular Cell CytokineHuman Neointima FormationTranscriptome AnalysisCell RegulationImmunology	2001	91
Effect of Glycoprotein IIb-IIIa Receptor Antagonism on Platelet Membrane Glycoproteins after Coronary Stent Placement Andreas Ruf, F. Neumann, Gisela Pogátsa-Murray, Thrombosis and Haemostasis	1998	76
Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty Thomas Nührenberg, Rainer Voisard, Felicitas Fahlisch, The FASEB Journal ImmunologyRenal InflammationVascular Wall InflammationProgenitor Cell PromotersInflammation	2004	56

Page 1